MedTrace Logo

Multicentre Study on Diabetic Foot Treatment

NCT05783115 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2023-03-24

No results posted yet for this study

Summary

With a rapidly growing incidence rate and a high disability rate,The Diabetic Foot has long been difficult to treatment, which has caused a huge burden to patients and society. The blood supply disorder is one of the main reasons that lead to the morbidity and difficulty in healing of diabetes feet, but there is still a lack of particularly effective treatment to improve the blood supply of diabetes feet. Both transverse bone transport and bone marrow cell transplantation have shown some clinical effects. However, the difference in efficacy between the two has not been reported. In this study, investigators compared the therapeutic effects of these two methods on the healing of diabetes foot ulcers through a controlled clinical study.

Conditions

  • Diabetic Foot

Interventions

PROCEDURE

Tibial Transportation Combined With Autologous mesenchymal stem cells Local Infusion

transverse bone transport with bone marrow cell transplantation

PROCEDURE

Tibial Transportation

transverse bone transport

Sponsors & Collaborators

  • Second Affiliated Hospital of Nantong University

    collaborator OTHER

  • Affiliated Hospital of Nantong University

    lead OTHER

Principal Investigators

  • Qinglin Han, Dr · Affiliated Hospital of Nantong University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2023-12-31
Completion
2024-07-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05783115 on ClinicalTrials.gov